Copyright Reports & Markets. All rights reserved.

Global API Drug Development Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global API Drug Development Service Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Captive Product Development Service
    • 1.3.3 Commercial Product Development Service
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global API Drug Development Service Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Small Biotechs Companies
    • 1.4.3 Large Pharmaceutical Organizations
  • 1.5 Global API Drug Development Service Market Size & Forecast
    • 1.5.1 Global API Drug Development Service Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global API Drug Development Service Sales Quantity (2019-2030)
    • 1.5.3 Global API Drug Development Service Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Lonza
    • 2.1.1 Lonza Details
    • 2.1.2 Lonza Major Business
    • 2.1.3 Lonza API Drug Development Service Product and Services
    • 2.1.4 Lonza API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Lonza Recent Developments/Updates
  • 2.2 Patheon
    • 2.2.1 Patheon Details
    • 2.2.2 Patheon Major Business
    • 2.2.3 Patheon API Drug Development Service Product and Services
    • 2.2.4 Patheon API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Patheon Recent Developments/Updates
  • 2.3 Catalent
    • 2.3.1 Catalent Details
    • 2.3.2 Catalent Major Business
    • 2.3.3 Catalent API Drug Development Service Product and Services
    • 2.3.4 Catalent API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Catalent Recent Developments/Updates
  • 2.4 Carbogen Amcis
    • 2.4.1 Carbogen Amcis Details
    • 2.4.2 Carbogen Amcis Major Business
    • 2.4.3 Carbogen Amcis API Drug Development Service Product and Services
    • 2.4.4 Carbogen Amcis API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Carbogen Amcis Recent Developments/Updates
  • 2.5 Sterling Pharma Solutions
    • 2.5.1 Sterling Pharma Solutions Details
    • 2.5.2 Sterling Pharma Solutions Major Business
    • 2.5.3 Sterling Pharma Solutions API Drug Development Service Product and Services
    • 2.5.4 Sterling Pharma Solutions API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sterling Pharma Solutions Recent Developments/Updates
  • 2.6 Cambrex
    • 2.6.1 Cambrex Details
    • 2.6.2 Cambrex Major Business
    • 2.6.3 Cambrex API Drug Development Service Product and Services
    • 2.6.4 Cambrex API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Cambrex Recent Developments/Updates
  • 2.7 CordenPharma
    • 2.7.1 CordenPharma Details
    • 2.7.2 CordenPharma Major Business
    • 2.7.3 CordenPharma API Drug Development Service Product and Services
    • 2.7.4 CordenPharma API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 CordenPharma Recent Developments/Updates
  • 2.8 Eurofins Scientific
    • 2.8.1 Eurofins Scientific Details
    • 2.8.2 Eurofins Scientific Major Business
    • 2.8.3 Eurofins Scientific API Drug Development Service Product and Services
    • 2.8.4 Eurofins Scientific API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Eurofins Scientific Recent Developments/Updates
  • 2.9 Malvern Panalytical
    • 2.9.1 Malvern Panalytical Details
    • 2.9.2 Malvern Panalytical Major Business
    • 2.9.3 Malvern Panalytical API Drug Development Service Product and Services
    • 2.9.4 Malvern Panalytical API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Malvern Panalytical Recent Developments/Updates
  • 2.10 Almac
    • 2.10.1 Almac Details
    • 2.10.2 Almac Major Business
    • 2.10.3 Almac API Drug Development Service Product and Services
    • 2.10.4 Almac API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Almac Recent Developments/Updates
  • 2.11 Pfizer
    • 2.11.1 Pfizer Details
    • 2.11.2 Pfizer Major Business
    • 2.11.3 Pfizer API Drug Development Service Product and Services
    • 2.11.4 Pfizer API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Pfizer Recent Developments/Updates
  • 2.12 Axplora
    • 2.12.1 Axplora Details
    • 2.12.2 Axplora Major Business
    • 2.12.3 Axplora API Drug Development Service Product and Services
    • 2.12.4 Axplora API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Axplora Recent Developments/Updates
  • 2.13 Aptuit
    • 2.13.1 Aptuit Details
    • 2.13.2 Aptuit Major Business
    • 2.13.3 Aptuit API Drug Development Service Product and Services
    • 2.13.4 Aptuit API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Aptuit Recent Developments/Updates
  • 2.14 Porton
    • 2.14.1 Porton Details
    • 2.14.2 Porton Major Business
    • 2.14.3 Porton API Drug Development Service Product and Services
    • 2.14.4 Porton API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Porton Recent Developments/Updates
  • 2.15 Pharmaron Beijing
    • 2.15.1 Pharmaron Beijing Details
    • 2.15.2 Pharmaron Beijing Major Business
    • 2.15.3 Pharmaron Beijing API Drug Development Service Product and Services
    • 2.15.4 Pharmaron Beijing API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Pharmaron Beijing Recent Developments/Updates
  • 2.16 Shanghai Haoyuan Chemexpress
    • 2.16.1 Shanghai Haoyuan Chemexpress Details
    • 2.16.2 Shanghai Haoyuan Chemexpress Major Business
    • 2.16.3 Shanghai Haoyuan Chemexpress API Drug Development Service Product and Services
    • 2.16.4 Shanghai Haoyuan Chemexpress API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Shanghai Haoyuan Chemexpress Recent Developments/Updates
  • 2.17 Stapharma
    • 2.17.1 Stapharma Details
    • 2.17.2 Stapharma Major Business
    • 2.17.3 Stapharma API Drug Development Service Product and Services
    • 2.17.4 Stapharma API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Stapharma Recent Developments/Updates

3 Competitive Environment: API Drug Development Service by Manufacturer

  • 3.1 Global API Drug Development Service Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global API Drug Development Service Revenue by Manufacturer (2019-2024)
  • 3.3 Global API Drug Development Service Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of API Drug Development Service by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 API Drug Development Service Manufacturer Market Share in 2023
    • 3.4.3 Top 6 API Drug Development Service Manufacturer Market Share in 2023
  • 3.5 API Drug Development Service Market: Overall Company Footprint Analysis
    • 3.5.1 API Drug Development Service Market: Region Footprint
    • 3.5.2 API Drug Development Service Market: Company Product Type Footprint
    • 3.5.3 API Drug Development Service Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global API Drug Development Service Market Size by Region
    • 4.1.1 Global API Drug Development Service Sales Quantity by Region (2019-2030)
    • 4.1.2 Global API Drug Development Service Consumption Value by Region (2019-2030)
    • 4.1.3 Global API Drug Development Service Average Price by Region (2019-2030)
  • 4.2 North America API Drug Development Service Consumption Value (2019-2030)
  • 4.3 Europe API Drug Development Service Consumption Value (2019-2030)
  • 4.4 Asia-Pacific API Drug Development Service Consumption Value (2019-2030)
  • 4.5 South America API Drug Development Service Consumption Value (2019-2030)
  • 4.6 Middle East & Africa API Drug Development Service Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global API Drug Development Service Sales Quantity by Type (2019-2030)
  • 5.2 Global API Drug Development Service Consumption Value by Type (2019-2030)
  • 5.3 Global API Drug Development Service Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global API Drug Development Service Sales Quantity by Application (2019-2030)
  • 6.2 Global API Drug Development Service Consumption Value by Application (2019-2030)
  • 6.3 Global API Drug Development Service Average Price by Application (2019-2030)

7 North America

  • 7.1 North America API Drug Development Service Sales Quantity by Type (2019-2030)
  • 7.2 North America API Drug Development Service Sales Quantity by Application (2019-2030)
  • 7.3 North America API Drug Development Service Market Size by Country
    • 7.3.1 North America API Drug Development Service Sales Quantity by Country (2019-2030)
    • 7.3.2 North America API Drug Development Service Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe API Drug Development Service Sales Quantity by Type (2019-2030)
  • 8.2 Europe API Drug Development Service Sales Quantity by Application (2019-2030)
  • 8.3 Europe API Drug Development Service Market Size by Country
    • 8.3.1 Europe API Drug Development Service Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe API Drug Development Service Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific API Drug Development Service Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific API Drug Development Service Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific API Drug Development Service Market Size by Region
    • 9.3.1 Asia-Pacific API Drug Development Service Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific API Drug Development Service Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America API Drug Development Service Sales Quantity by Type (2019-2030)
  • 10.2 South America API Drug Development Service Sales Quantity by Application (2019-2030)
  • 10.3 South America API Drug Development Service Market Size by Country
    • 10.3.1 South America API Drug Development Service Sales Quantity by Country (2019-2030)
    • 10.3.2 South America API Drug Development Service Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa API Drug Development Service Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa API Drug Development Service Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa API Drug Development Service Market Size by Country
    • 11.3.1 Middle East & Africa API Drug Development Service Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa API Drug Development Service Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 API Drug Development Service Market Drivers
  • 12.2 API Drug Development Service Market Restraints
  • 12.3 API Drug Development Service Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of API Drug Development Service and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of API Drug Development Service
  • 13.3 API Drug Development Service Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 API Drug Development Service Typical Distributors
  • 14.3 API Drug Development Service Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global API Drug Development Service market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global API Drug Development Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global API Drug Development Service market size and forecasts, in consumption value ($ Million), 2019-2030
    Global API Drug Development Service market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global API Drug Development Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global API Drug Development Service market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for API Drug Development Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global API Drug Development Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Patheon, Catalent, Carbogen Amcis, Sterling Pharma Solutions, Cambrex, CordenPharma, Eurofins Scientific, Malvern Panalytical, Almac, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    API Drug Development Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    API Drug Development Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Captive Product Development Service
    Commercial Product Development Service
    Market segment by Application
    Small Biotechs Companies
    Large Pharmaceutical Organizations
    Market segment by players, this report covers
    Lonza
    Patheon
    Catalent
    Carbogen Amcis
    Sterling Pharma Solutions
    Cambrex
    CordenPharma
    Eurofins Scientific
    Malvern Panalytical
    Almac
    Pfizer
    Axplora
    Aptuit
    Porton
    Pharmaron Beijing
    Shanghai Haoyuan Chemexpress
    Stapharma
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe API Drug Development Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of API Drug Development Service, with revenue, gross margin, and global market share of API Drug Development Service from 2019 to 2024.
    Chapter 3, the API Drug Development Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and API Drug Development Service market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of API Drug Development Service.
    Chapter 13, to describe API Drug Development Service research findings and conclusion.

    Buy now